Qingqing Xia

1.3k total citations
59 papers, 933 citations indexed

About

Qingqing Xia is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Qingqing Xia has authored 59 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Qingqing Xia's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Cancer-related molecular mechanisms research (6 papers) and Asthma and respiratory diseases (6 papers). Qingqing Xia is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Cancer-related molecular mechanisms research (6 papers) and Asthma and respiratory diseases (6 papers). Qingqing Xia collaborates with scholars based in China, United States and Switzerland. Qingqing Xia's co-authors include Yufeng Zhang, Weilong Jiang, Hongning Wang, Di Cui, Min Liu, Xiaolei Zhang, Anyun Zhang, Haibo Gu, Qi Jia and Jia Qi and has published in prestigious journals such as The Journal of Immunology, Biomaterials and Scientific Reports.

In The Last Decade

Qingqing Xia

51 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingqing Xia China 17 364 144 103 102 75 59 933
Bong-Soo Park South Korea 26 790 2.2× 162 1.1× 91 0.9× 82 0.8× 28 0.4× 85 1.9k
David Haschka Austria 22 339 0.9× 59 0.4× 80 0.8× 127 1.2× 36 0.5× 42 1.5k
Bruno Colaço Portugal 23 584 1.6× 158 1.1× 62 0.6× 105 1.0× 48 0.6× 121 1.7k
Boram Kim South Korea 20 315 0.9× 53 0.4× 61 0.6× 104 1.0× 38 0.5× 114 1.3k
Mario Salmeri Italy 19 414 1.1× 101 0.7× 43 0.4× 82 0.8× 28 0.4× 50 1.2k
Chuanhui Xu China 16 375 1.0× 115 0.8× 71 0.7× 42 0.4× 15 0.2× 62 1.0k
Yuhang Chen China 19 395 1.1× 68 0.5× 43 0.4× 109 1.1× 19 0.3× 109 1.1k
Vilma Lima Brazil 21 361 1.0× 72 0.5× 119 1.2× 171 1.7× 16 0.2× 42 1.4k
Renata Ferreira de Carvalho Leitão Brazil 23 420 1.2× 94 0.7× 42 0.4× 361 3.5× 45 0.6× 75 1.7k

Countries citing papers authored by Qingqing Xia

Since Specialization
Citations

This map shows the geographic impact of Qingqing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqing Xia more than expected).

Fields of papers citing papers by Qingqing Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingqing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqing Xia. The network helps show where Qingqing Xia may publish in the future.

Co-authorship network of co-authors of Qingqing Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Qingqing Xia. A scholar is included among the top collaborators of Qingqing Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingqing Xia. Qingqing Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xia, Qingqing, Dantong Sun, Chengcheng Liu, et al.. (2025). Lactylation: the metabolic–immune hub in autoimmune diseases. Frontiers in Immunology. 16. 1651923–1651923.
3.
Xia, Qingqing, et al.. (2025). Identification of inverted U-shaped curve association between serum potassium and prodromal Parkinson’s disease. Clinical Parkinsonism & Related Disorders. 12. 100323–100323.
4.
Li, Min, L. Cao, Zepeng Zhang, et al.. (2025). Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications. Frontiers in Pharmacology. 16. 1534634–1534634. 10 indexed citations
5.
Cao, Liyuan, Lu Ding, Qingqing Xia, et al.. (2025). Macrophage polarization in diabetic vascular complications: mechanistic insights and therapeutic targets. Journal of Translational Medicine. 23(1). 1050–1050. 1 indexed citations
6.
Xia, Qingqing, et al.. (2025). The HALP score differs among sporadic and familial Parkinson's disease. Parkinsonism & Related Disorders. 133. 107305–107305. 1 indexed citations
7.
Yin, Kai, Lu Ding, Xueyan Li, et al.. (2025). Causal role of plasma liposome in diabetic retinopathy: mendelian randomization (MR) study. Diabetology & Metabolic Syndrome. 17(1). 47–47.
8.
Wu, Yongchao, Zhigang Li, S. Li, et al.. (2025). Inhibition of hepatocellular carcinoma progression by artesunate via modulation of the TLR4/MyD88/NF-κB signaling pathway. Journal of Gastrointestinal Oncology. 16(2). 599–614. 1 indexed citations
9.
Song, Biao, Dong Sun, Qingqing Xia, et al.. (2025). BMP9 suppresses TNF-α-induced inflammatory response in fibroblast-like synoviocytes through Smad pathway in rheumatoid arthritis. International Immunopharmacology. 166. 115544–115544.
10.
Xia, Qingqing & Sandrine Pierson. (2025). HPV Infection and Oral Microbiota: Interactions and Future Implications. International Journal of Molecular Sciences. 26(4). 1424–1424. 3 indexed citations
12.
Wang, Jinyu, et al.. (2024). Echinacoside inhibits PASMCs calcium overload to prevent hypoxic pulmonary artery remodeling by regulating TRPC1/4/6 and calmodulin. Open Medicine. 19(1). 20241044–20241044. 2 indexed citations
14.
Xia, Qingqing, et al.. (2024). S-HGMS coupling with alkali precipitation for the scale inhibition in recirculating cooling water with high hardness: Performance, mechanism and field application. Separation and Purification Technology. 342. 127048–127048. 4 indexed citations
15.
Wu, Yongchao, Guang Yang, Zhigang Li, et al.. (2023). Conservative treatment of hepatic portal vein gas after transarterial chemoembolization treatment for liver metastasis of postoperative esophageal cancer: a case report. Journal of Gastrointestinal Oncology. 14(2). 1166–1174. 2 indexed citations
16.
Han, Jasmine J., et al.. (2023). Emerging Infectious Diseases Are Virulent Viruses—Are We Prepared? An Overview. Microorganisms. 11(11). 2618–2618. 11 indexed citations
17.
Qing, Yi, Cong Wang, Qingqing Xia, et al.. (2022). A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma. Frontiers in Genetics. 13. 975185–975185. 24 indexed citations
18.
Li, Xing, et al.. (2021). P2X7 receptor-mediated phenotype switching of pulmonary artery smooth muscle cells in hypoxia. Molecular Biology Reports. 48(3). 2133–2142. 7 indexed citations
19.
Li, Jie, Qingqing Xia, Ke Yao, et al.. (2014). Involvement of Endoplasmic Reticulum Stress in All-Trans-Retinal-Induced Retinal Pigment Epithelium Degeneration. Toxicological Sciences. 143(1). 196–208. 46 indexed citations
20.
Zhu, Shouan, Ping Lü, Huanhuan Liu, et al.. (2013). Inhibition of Rac1 activity by controlled release of NSC23766 from chitosan microspheres effectively ameliorates osteoarthritis development in vivo. Annals of the Rheumatic Diseases. 74(1). 285–293. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026